GPC Biotech To Re-Schedule Annual Shareholders
GPC Biotech AG is a publicly traded biopharmaceutical company focused on anticancer drugs. GPC Biotech's lead product candidate is satraplatin, an oral platinum compound. The Company has various a......
7/17/2008 2:28:00 AM
Breaking Business News latest RSS headlines - St Louis Star.com
|
